APA (7th ed.) Citation

Tamura, K., Tohyama, T., Watanabe, J., Nakamura, T., Ueno, Y., Inoue, H., . . . Takada, Y. (2019). Preformed donor‐specific antibodies are associated with 90‐day mortality in living‐donor liver transplantation. Hepatology Research, 49(8), 929. https://doi.org/10.1111/hepr.13352

Chicago Style (17th ed.) Citation

Tamura, Kei, et al. "Preformed Donor‐specific Antibodies Are Associated with 90‐day Mortality in Living‐donor Liver Transplantation." Hepatology Research 49, no. 8 (2019): 929. https://doi.org/10.1111/hepr.13352.

MLA (9th ed.) Citation

Tamura, Kei, et al. "Preformed Donor‐specific Antibodies Are Associated with 90‐day Mortality in Living‐donor Liver Transplantation." Hepatology Research, vol. 49, no. 8, 2019, p. 929, https://doi.org/10.1111/hepr.13352.